On January 8th, two early investors in MMMG, LLC, a precursor company to MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) filed a complaint in Los Angeles Superior Court alleging unfair treatment regarding the disposition of their investment in MMMG.
The cost to finance a new short position in the cannabis company soared to as high as 900 percent on Wednesday, data by financial analytics firm S3 Partners LLC show…
The Morning Blunt
Aphria Inc (NYSE: APHA) is scheduled to release its earnings report for Q2 2019 on January 11. Investors should handle this stock with extreme care — Aphria is en…
Piper Jaffray initiated coverage on cannabis producers, joining a short — but growing — list of Wall Street brokerages watching the industry. Bullish on Tilray (NASDAQ: TLRY) and Canopy Growth…
The time to buy stock in GW Pharmaceuticals, the UK-based company that produces FDA-approved cannabinoid-based medicines to treat epilepsy and other disea…
Aphria (APHA) will announce its fiscal 2019 second quarter results on January 11, 2019. The company has been embroiled in a series of events including the QCM/Hindenburg short attack and the recent hostile…
PR News Wire
Aphria Inc. (“Aphria” or the “Company”) (TSX: APHA and NYSE: APHA) announced today that it has completed its first shipment of medical cannabis to Shoppers Drug Mart (“SDM”).
Yesterday, an analyst has provided a rating update for the Healthcare company, Aurora Cannabis (ACB). GMP FirstEnergy’s analyst Martin Landry reiterates their Hold rating on the shares, with a C$7.50 price target.
KushCo Holdings Inc KSHB 2.52%, a provider of ancillary products and services to the cannabis industry, reported Q1 results after the close Tuesday. Although the company’s revenue almost tripled over the year, its bottom line turned negative.
Earlier this week, the North American Marijuana Index conducted its quarterly rebalancing, adding a total of 12 new companies to the Index, with 10 going to the United States Marijuana Index and two attached to the Canadian Index.
Globe News Wire
Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the “Company”) is pleased to announce that, further to its previous releases, it has completed the acquisition of 80%…
One company that we have been especially favorable on is Liberty Health Sciences (LHS.CN) (LHSIF) and this is a company that investors should be watching.
The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1) announced today that it has received conditional approval from the Toronto Stock Exchange
Hasan addresses the difficulties cannabis companies face in California with regards to the lingering illicit market and the repercussions of price …
Canadians are paying nearly 50 per cent more for their legal cannabis when compared to illegal sources, according to an analysis of price quotes by Statistics Canada on Wednesday…
According to New Frontier Data, investors made $10 billion dollars of investments into the cannabis industry in North America in the past year alone.
With the rapid spread of marijuana legalization in the US, lawyers are …. The firm has made a push to grow its presence in California, and cannabis …
The Arizona Supreme Court will take up the open question of cannabis extracts’ status under the state’s medical marijuana law, as Arizona v.
Marijuana would be legalized in Virginia under a bill that was introduced on Tuesday. It’s one of more than 10 pieces of cannabis-related legislation that lawmakers in the commonwealth could consider this legislative session.
Ohio’s first medical marijuana sales could happen at the end of next week – provided everything happens as planned. Medical marijuana has been …
The arrival of 2019 brought changes in the California cannabis licensing process, the potential for Santa Barbara County cannabis ordinance …
California’s Cannabis Advisory Committee (CAC) recently published their full 2018 Annual Report to the Bureau of Cannabis Control’s website.
Canada’s pot shortage could last as long as three years, according to industry executives who say production estimates are too rosy.
Canopy Growth’s $3 million professorship looks to solve the opioid epidemic with cannabis — but it …
(TSX:WEED) (NYSE:CGC) recently announced the first Professor of Cannabis Science at the University of British Columbia, made possible by a $2.5 …
Cannabis Business Times: Can you describe some of the problems that the lack of federal pesticide regulations presents to hemp and cannabis …